Single-dose tranexamic acid in advanced ovarian cancer surgery reduces blood loss and transfusions: Double-blind placebo-controlled randomized multicenter study

Acta Obstetricia et Gynecologica Scandinavica

Volumn 93, Issue 4, 2014, Pages 335-344

  Lundin, Evelyn S ^a,b   Johansson, Torsten ^a,b   Zachrisson, Helene ^a,b   Leandersson, Ulf ^c   Bäckman, Fatma ^d   Falknäs, Laila ^e   Kjølhede, Preben ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b County Council of Östergötland   (Sweden)

^c KALMAR COUNTY HOSPITAL   (Sweden)

^d ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^e RYHOV COUNTY HOSPITAL   (Sweden)

Author keywords

Blood loss; ovarian cancer; randomized trial; surgery; tranexamic acid; transfusion

Indexed keywords

PLACEBO; TRANEXAMIC ACID;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DOUBLE BLIND PROCEDURE; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; INTENTION TO TREAT ANALYSIS; MULTICENTER STUDY; OPERATIVE BLOOD LOSS; OVARY CANCER; PARAMETRIC TEST; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SWEDEN; UNIVERSITY HOSPITAL;

BLOOD LOSS; OVARIAN CANCER; RANDOMIZED TRIAL; SURGERY; TRANEXAMIC ACID; TRANSFUSION;

ADULT; AGED; AGED, 80 AND OVER; ANTIFIBRINOLYTIC AGENTS; BLOOD LOSS, SURGICAL; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ERYTHROCYTE TRANSFUSION; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HEMOGLOBINS; HUMANS; INJECTIONS, INTRAVENOUS; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; OPERATIVE TIME; OVARIAN NEOPLASMS; OVARIECTOMY; PREOPERATIVE CARE; PRIMARY PREVENTION; SWEDEN; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 84897115198     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/aogs.12333     Document Type: Article

References (27)

1. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ,. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002; 20: 1248-59.
2. Schorge JO, McCann C, Del Carmen MG,. Surgical debulking of ovarian cancer: what difference does it make? Rev Obstet Gynecol. 2010; 3: 111-7.
3. Morrison J, Haldar K, Kehoe S, Lawrie TA,. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer. Cochrane Database Syst Rev. 2012;(8): CD005343. doi: 10.1002/14651858.CD005343.pub3
4. Abu-Rustum NR, Richard S, Wilton A, Lev G, Sonoda Y, Hensley ML, et al. Transfusion utilization during adnexal or peritoneal cancer surgery: effects on symptomatic venous thromboembolism and survival. Gynecol Oncol. 2005; 99: 320-6.
5. Nielsen HJ,. Detrimental effects of perioperative blood transfusion. Br J Surg. 1995; 82: 582-7.
6. Lindoff C, Rybo G, Åstedt B,. Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications. Thromb Haemost. 1993; 70: 238-40.
7. Dunn CJ, Goa KL,. Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999; 57: 1005-32.
8. Ker K, Edwards P, Perel P, Shakur H, Roberts I,. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012; 344: e3054.
9. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2011;(3): CD001886. doi: 10.1002/14651858.CD001886.pub4
10. Perel P, Ker K, Morales Uribe CH, Roberts I,. Tranexamic acid for reducing mortality in emergency and urgent surgery. Cochrane Database Syst Rev. 2013;(1): CD010245. doi: 10.1002/14651858.CD010245.pub2
11. Sukeik M, Alshryda S, Haddad FS, Mason JM,. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br. 2011; 93: 39-46.
12. Alshryda S, Sarda P, Sukeik M, Nargol A, Blenkinsopp J, Mason JM,. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br. 2011; 93: 1577-85.
13. Celebi N, Celebioglu B, Selcuk M, Canbay O, Karagoz AH, Aypar U,. The role of antifibrinolytic agents in gynecologic cancer surgery. Saudi Med J. 2006; 27: 637-41.
14. European Medicines Agency. Good Clinical Practice Guidelines. Available online at: http://www.ema.europa.eu/docs/en-GB/document-library/Scientific- guideline/2009/09/WC500002874.pdf (accessed 11 November, 2013).
15. Schellong SM, Beyer J, Kakkar AK, Halbritter K, Eriksson BI, Turpie AG, et al. Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study. J Thromb Haemost. 2007; 5: 1431-7.
16. Brecher ME, Monk T, Goodnough LT,. A standardized method for calculating blood loss. Transfusion. 1997; 37: 1070-4.
17. Nadler SB, Hidalgo JU, Bloch T,. Prediction of blood volume in normal human adults. Surgery. 1962; 51: 224-32.
18. Altman DG, Dore CJ,. Randomisation and baseline comparisons in clinical trials. Lancet. 1990; 335: 149-53.
19. Johansson T, Lisander B, Ivarsson I,. Mild hypothermia does not increase blood loss during hip arthroplasty. Acta Anaesthesiol Scand. 1999; 43: 1005-10.
20. Meunier A, Petersson A, Good L, Berlin G,. Validation of a haemoglobin dilution method for estimation of blood loss. Vox Sang. 2008; 95: 120-4.
21. Chi DS, Zivanovic O, Levinson KL, Kolev V, Huh J, Dottino J, et al. The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas. Gynecol Oncol. 2010; 119: 38-42.
22. Eisner RF, Montz FJ, Berek JS,. Cytoreductive surgery for advanced ovarian cancer: cardiovascular evaluation with pulmonary artery catheters. Gynecol Oncol. 1990; 37: 311-4.
23. Oertli D, Laffer U, Haberthuer F, Kreuter U, Harder F,. Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer. Br J Surg. 1994; 81: 856-9.
24. Crescenti A, Borghi G, Bignami E, Bertarelli G, Landoni G, Casiraghi GM, et al. Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trial. BMJ. 2011; 343: d5701.
25. Johansson T, Pettersson LG, Lisander B,. Tranexamic acid in total hip arthroplasty saves blood and money: a randomized, double-blind study in 100 patients. Acta Orthop. 2005; 76: 314-9.
26. Benoni G, Lethagen S, Nilsson P, Fredin H,. Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty. Acta Orthop Scand. 2000; 71: 250-4.
27. Tateo S, Mereu L, Salamano S, Klersy C, Barone M, Spyropoulos AC, et al. Ovarian cancer and venous thromboembolic risk. Gynecol Oncol. 2005; 99: 119-25.